---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018911"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:42:39.504215+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# INVO Fertility sells $500k of Series C-2 Preferred to existing holder; conversion price set at $0.6285

## Summary
- Institutional investor exercised Additional Investment Right to buy 500 shares of Series C-2 Preferred for $500,000 cash.
- Conversion price on C-2 Preferred adjusted to $0.6285 per share following the exercise.
- Securities issued without registration under Section 4(a)(2) and Rule 506 of the Securities Act.

## SEC filing metadata
- accession: 0001493152-25-018911
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02, 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315225018911/0001493152-25-018911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315225018911/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018911
- JSON: https://secwatch.observer/filing/0001493152-25-018911.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018911.txt

## Key facts
- Equity Issuances
  INVO Fertility, Inc. issued 500 shares of C-2 Preferred of preferred stock to an institutional investor and existing holder for $500,000 in cash.
  - Security: preferred stock
  - Shares: 500 shares of C-2 Preferred
  - Purchaser: an institutional investor and existing holder
  - Consideration: $500,000 in cash
  source text: a party pursuant to a joinder agreement (the “ Joinder Agreement ”) on October 11, 2024), to acquire 500 shares of C-2 Preferred, with an aggregate stated value of $500,000, for $500,000 in cash. As a result of the exercise, the conversion price on the C-2 Preferred adjusted to $0.6285 per share. The C-2 Preferred issued pursuant to this exercise were
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315225018911/0001493152-25-018911-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.